Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Hay

Showing results (331-340 of 423) with videos related to

Pageof 43
Sort By:
Hepatology (Baltimore, Md.)|November 1, 1992
Selection and timing of liver transplantation in primary biliary cirrhosis and primary sclerosing cholangitisR H Wiesner, M K Porayko, E R Dickson, et al.
Current Oncology (Toronto, Ont.)|July 7, 2017
Linkage of clinical trial and administrative data: a survey of cancer patient preferencesA E Hay, Y W Leung, J L Pater, et al.
The Oncologist|May 25, 2023
Contact Days Associated With Cancer Treatments in the CCTG LY.12 TrialArjun Gupta, Annette E Hay, Michael Crump, et al.
Hypertension (Dallas, Tex. : 1979)|January 1, 1994
Systemic and renal effects of nifedipine in cyclosporine-associated hypertensionS C Textor, L Schwartz, D J Wilson, et al.
Journal of the National Cancer Institute|March 24, 2021
Application of Value Frameworks to the Design of Clinical Trials: The Canadian Cancer Trials Group ExperienceJoseph C Del Paggio, Adam M Fundytus, Wilma M Hopman, et al.
Kidney International|May 1, 1995
Urinary endothelin and renal vasoconstriction with cyclosporine or FK506 after liver transplantationS C Textor, J C Burnett, J C Romero, et al.
Antimicrobial Agents and Chemotherapy|February 4, 2009
Steady-state pharmacokinetics of abacavir in plasma and intracellular carbovir triphosphate following administration of abacavir at 600 milligrams once daily and 300 milligrams twice daily in human immunodeficiency virus-infected subjectsGraeme Moyle, Marta Boffito, Carl Fletcher, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|April 12, 2023
Health-related quality of life in early-stage Hodgkin lymphoma: a longitudinal analysis of the ABVD arm in the randomized controlled trial HD.6Hira Mian, Jolie Ringash, Ralph Meyer, et al.
Organic Letters|November 5, 2005
Antineoplastic diterpene-benzoate macrolides from the Fijian red alga Callophycus serratusJulia Kubanek, Anne C Prusak, Terry W Snell, et al.
Transplantation|June 1, 1993
Systemic and renal hemodynamic differences between FK506 and cyclosporine in liver transplant recipientsS C Textor, R Wiesner, D J Wilson, et al.
Pageof 43

Showing results (331-340 of 423) with videos related to

Sort By:
Pageof 43
Hepatology (Baltimore, Md.)|November 1, 1992
Selection and timing of liver transplantation in primary biliary cirrhosis and primary sclerosing cholangitisR H Wiesner, M K Porayko, E R Dickson, et al.
Current Oncology (Toronto, Ont.)|July 7, 2017
Linkage of clinical trial and administrative data: a survey of cancer patient preferencesA E Hay, Y W Leung, J L Pater, et al.
The Oncologist|May 25, 2023
Contact Days Associated With Cancer Treatments in the CCTG LY.12 TrialArjun Gupta, Annette E Hay, Michael Crump, et al.
Hypertension (Dallas, Tex. : 1979)|January 1, 1994
Systemic and renal effects of nifedipine in cyclosporine-associated hypertensionS C Textor, L Schwartz, D J Wilson, et al.
Journal of the National Cancer Institute|March 24, 2021
Application of Value Frameworks to the Design of Clinical Trials: The Canadian Cancer Trials Group ExperienceJoseph C Del Paggio, Adam M Fundytus, Wilma M Hopman, et al.
Kidney International|May 1, 1995
Urinary endothelin and renal vasoconstriction with cyclosporine or FK506 after liver transplantationS C Textor, J C Burnett, J C Romero, et al.
Antimicrobial Agents and Chemotherapy|February 4, 2009
Steady-state pharmacokinetics of abacavir in plasma and intracellular carbovir triphosphate following administration of abacavir at 600 milligrams once daily and 300 milligrams twice daily in human immunodeficiency virus-infected subjectsGraeme Moyle, Marta Boffito, Carl Fletcher, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|April 12, 2023
Health-related quality of life in early-stage Hodgkin lymphoma: a longitudinal analysis of the ABVD arm in the randomized controlled trial HD.6Hira Mian, Jolie Ringash, Ralph Meyer, et al.
Organic Letters|November 5, 2005
Antineoplastic diterpene-benzoate macrolides from the Fijian red alga Callophycus serratusJulia Kubanek, Anne C Prusak, Terry W Snell, et al.
Transplantation|June 1, 1993
Systemic and renal hemodynamic differences between FK506 and cyclosporine in liver transplant recipientsS C Textor, R Wiesner, D J Wilson, et al.
Pageof 43